Differences between patients with a preserved and a depressed left ventricular function: A report from the EuroHeart Failure Survey

European Heart Journal

Volumn 25, Issue 14, 2004, Pages 1214-1220

  Lenzen, M J ^a   Scholte Op Reimer, W J M ^a   Boersma, E ^a   Vantrimpont, P J M J ^a   Follath, F ^b   Swedberg, K ^c   Cleland, J ^d   Komajda, M ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF HULL   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

EuroHeart survey; Heart failure; Left ventricular systolic dysfunction; Preserved left ventricular function

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; STATIN; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPECIES COMPARISON;

AGED; FEMALE; HEALTH SURVEYS; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 3042715684     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.06.006     Document Type: Article

References (27)

1. Khand A., Gemmel I., Clark A.L., et al. Is the prognosis of heart failure improving. J. Am. Coll. Cardiol. 36:2000;2284-2286
2. Ho K.K., Pinsky J.L., Kannel W.B., et al. The epidemiology of heart failure: the Framingham Study. J. Am. Coll. Cardiol. 22:1993;6A-13A
3. Cleland J.G., Swedberg K., Poole-Wilson P.A. Successes and failures of current treatment of heart failure. Lancet. 352(Suppl 1):1998;SI19-SI28
4. Schaufelberger M.S.K., Köster M., et al. Decreasing One-year Mortality and Hospitalisation Rates for Heart Failure in Sweden. Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur. Heart J. 25:2004;300-307
5. The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 1997;18:736-53
6. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22:2001;1527-1560
7. Banerjee P., Banerjee T., Khand A., et al. Diastolic heart failure: neglected or misdiagnosed? J. Am. Coll. Cardiol. 39:2002;138-141
8. Komajda M., Follath F., Swedberg K., et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe: Part 2: treatment. Eur. Heart J. 24:2003;464-474
9. Cleland J.G.F., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. Eur. Heart J. 24:2003;442-463
10. Cleland J.G.F., Swedberg K., Cohen-Solal A., et al. The euro heart failure survey of The EUROHEART survey programme: a survey on the quality of care among patients with heart failure in Europe. Eur. J. Heart Fail. 2:2000;123-132
11. Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. Eur Heart J 1995;16:741-51
12. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003
13. Zile M.R. Heart failure with preserved ejection fraction: is this diastolic heart failure? J. Am. Coll. Cardiol. 41:2003;1519-1522
14. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 362:2003;759-766
15. Cowie M.R., Wood D.A., Coats A.J.S., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 83:2000;505-510
16. Mosterd A., Cost B., Hoes A.W., et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur. Heart J. 22:2001;1318-1327
17. Cohen-Solal A., Desnos M., Delahaye F., et al. A national survey of heart failure in French hospitals. Eur. Heart J. 21:2000;763-769
18. Senni M., Redfield M.M. Heart failure with preserved systolic function: a different natural history. J. Am. Coll. Cardiol. 38:2001;1277-1282
19. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J. Am. Coll. Cardiol. 41:2003;1510-1518
20. Masoudi F.A., Havranek E.P., Smith G., et al. Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol. 41:2003;217-223
21. Gustafsson F., Torp-Pedersen C., Brendorp B., et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur. Heart J. 24:2003;863-870
22. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 362:2003;777-781
23. Granger C.B., McMurray J.J.V., Yusuf S., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 362:2003;772-776
24. McMurray J., Ostergren J., Pfeffer M., et al. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity CHARM programme. Eur. J. Heart Fail. 5:2003;261-270
25. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 105:2002;1387-1393
26. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33
27. Cleland J.G.F., Cohen-Solal A., Aguilar J.C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 360:2002;1631-1639